Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Higher plasma soluble TREM2 correlates with reduced cerebral tau accumulation in Alzheimer's disease 2025-04-01
  2. Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer's disease patients and cognitively normal individuals 2024-06-28
  3. Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease 2022-04-01

Studies

3 studies carry this tag.

Date range

2022 to 2025

Top journals

  • Alzheimer's research & therapy 1
  • Molecular psychiatry 1
  • Science advances 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Higher plasma soluble TREM2 correlates with reduced cerebral tau accumulation in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Molecular psychiatry 2025-04-01 Biomarkers

    Loss-of-function mutation of triggering receptor expressed on myeloid cell 2 (TREM2) is associated with increased risks for Alzheimer's disease (AD).

  2. Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer's disease patients and cognitively normal individuals

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Alzheimer's research & therapy 2024-06-28 Biomarkers

    Soluble plasma Aβ42/40 ratio is the most robust biomarker to discriminate between AD patients and CN individuals, as it normalizes for the number of NDEVs.

  3. Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Science advances 2022-04-01 Biomarkers

    CD22 has been suggested to contribute to Alzheimer's disease (AD) pathogenesis by inhibiting microglial amyloid β (Aβ) phagocytosis.

All topic tags with their study counts